(Q40991764)

25 September 2017

1 reference

title

Nitrates in the treatment of congestive heart failure (English)

1 reference

25 September 2017

main subject

congestive heart failure

1 reference

Elkayam U

1

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 May 1996

1 reference

American Journal of Cardiology

25 September 2017

published in

1 reference

25 September 2017

volume

77

1 reference

25 September 2017

issue

13

1 reference

25 September 2017

page(s)

41C-51C

1 reference

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900188-9

Effect of in vitro organic nitrate tolerance on relaxation, cyclic GMP accumulation, and guanylate cyclase activation by glyceryl trinitrate and the enantiomers of isoidide dinitrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900188-9

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900188-9

Potentiation of isosorbide dinitrate effects with N-acetylcysteine in patients with chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900188-9

Persistent hemodynamic improvement with short-term nitrate therapy in patients with chronic congestive heart failure already treated with captopril

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900188-9

Incidence of early tolerance to hemodynamic effects of continuous infusion of nitroglycerin in patients with coronary artery disease and heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900188-9

Prevention and reversal of nitrate tolerance in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900188-9

Tolerance to intravenous nitroglycerin in patients with congestive heart failure: role of increased intravascular volume, neurohumoral activation and lack of prevention with N-acetylcysteine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900188-9

Early tolerance to hemodynamic effects of high dose transdermal nitroglycerin in responders with severe chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900188-9

Comparative effects of captopril and isosorbide dinitrate on pulmonary arteriolar resistance and right ventricular function in patients with severe left ventricular failure: results of a randomized crossover study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900188-9

Hemodynamic and volumetric effects of venodilation with nitroglycerin in chronic mitral regurgitation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900188-9

Improvement in supine bicycle exercise performance in refractory congestive heart failure after isosorbide dinitrate: Radionuclide and hemodynamic evaluation of acute effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900188-9

Quantitative echocardiography of the mitral complex in dilated cardiomyopathy: the mechanism of functional mitral regurgitation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900188-9

Mechanism of reduction of mitral regurgitation with vasodilator therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900188-9

A randomized comparison between the hemodynamic effects of hydralazine and nitroglycerin alone and in combination at rest and during isometric exercise in patients with chronic mitral regurgitation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900188-9

Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900188-9

Contrasting immediate and long-term effects of isosorbide dinitrate on exercise capacity in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900188-9

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900188-9

Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900188-9

Enhancement of endothelium-dependent vasodilation by low-dose nitroglycerin in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900188-9

Impact of left ventricular unloading after late reperfusion of canine anterior myocardial infarction on remodeling and function using isosorbide-5-mononitrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900188-9

Intravenous nitroglycerin unloading in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900188-9

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900188-9

Resistance to isosorbide dinitrate in patients with severe chronic heart failure: Incidence and attempt at hemodynamic prediction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900188-9

Pharmacokinetic-hemodynamic studies of intravenous nitroglycerin in congestive cardiac failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900188-9

Hemodynamic and hormonal effects of high-dose transdermal nitroglycerin in patients with chronic congestive heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900188-9

Ineffectiveness of sublingual nitroglycerin in acute left ventricular failure in the presence of massive peripheral edema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900188-9

Dose requirements of hydralazine in patients with severe chronic congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900188-9

Randomized study to evaluate the relation between oral isosorbide dinitrate dosing interval and the development of early tolerance to its effect on left ventricular filling pressure in patients with chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900188-9

Potentiation of the hemodynamic effects of acutely administered nitroglycerin by methionine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900188-9

Tolerance to organic nitrates: evidence, mechanisms, clinical relevance, and strategies for prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900188-9

In vivo induction and reversal of nitroglycerin tolerance in human coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900188-9

Nitrate tolerance in vivo is not associated with depletion of arterial or venous thiol levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900188-9

Potentiation of the cardiovascular effects of nitroglycerin by N-acetylcysteine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900188-9

Failure of captopril to prevent nitrate tolerance in congestive heart failure secondary to coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900188-9

Hemodynamic effects of intermittent transdermal nitroglycerin in chronic congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900188-9

Concurrent hydralazine administration prevents nitroglycerin-induced hemodynamic tolerance in experimental heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900188-9

Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900188-9

Interaction between hydralazine and nitrovasodilators in vascular smooth muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900188-9

Comparison of the hemodynamic responses to molsidomine and isosorbide dinitrate in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900188-9

Hydralazine in the long-term treatment of chronic heart failure: lack of difference from placebo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900188-9

Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: the Hy-C trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900188-9

10.1016/S0002-9149(96)00188-9

7 January 2021

Identifiers

DOI

1 reference

25 September 2017

1 reference